Azalea Therapeutics was named to the Endpoints 11, "biotech's most exciting startups of 2026. Read the full story at Endpoints News (paywall).
Read post
QUANTUM INSIDER – Azulene plans to use the funding to expand its team and product development as it works with biotechnology and industrial chemistry customers.
Read post
The magazine of the California Alumni Association recently toured Bakar Bio Labs, speaking with our staff and entrepreneurs Chris Eiben of GigaCrop and Chad Miller of ResVita Bio. Check out the story for an inside view of our building and a better understanding of what's cooking at "the most beautiful biotech incubator in the world."
Read post
HexemBio recently announced two new therapies under development: an injectable that would deliver results similar to their flagship therapy, without the need to first collect cells from patients, and another therapy aimed at protecting and treating skin. The company, backed by $15.5M in funding, also brought on an additional investor, Happiness Capital.
Read post
AUTHORITY MAGAZINE – "As someone who has spent 40 years in diagnostics, I have tremendous passion for finding unmet needs that can be solved through diagnostics. We hear a lot about investment in treatments, but you don’t start treating someone until they’ve been diagnosed. I’ve always believed diagnostics are where healthcare begins."
Read post
UC BERKELEY NEWS — The annual PitchBook rankings again showed how Berkeley's commitment to innovation and entrepreneurship operates at a scale unmatched by any other university.
Read post
CEO Zilong Wang and CSO Seokjung Cheong are lead authors of a paper demonstrating how biology can help systematically expand the molecular design space for advanced, recyclable materials.
Read post
Root Applied Sciences has set up spore capture devices across the southern tier of Minnesota. The company developed its approach while pioneering detection and treatment for diseases that affect grapevines at vineyards. To protect their valuable produce, winemakers were spraying numerous times across a growing season. Root Applied Sciences developed a way of detecting and modeling infection that allowed those growers to cut their application in half.
Read post
The Berkeley Innovation Zone on the west side of UC Berkeley -- between campus and downtown -- showcases how the City of Berkeley is working with the university to welcome and support entrepreneurs, in a cultural change that could ultimately bring in more revenue. BIZ includes two incubators currently under construction: IGI-Bakar Labs and Bakar Labs for Energy & Materials.
Read post
Turner Construction Company joined the University of California, Berkeley, the Innovative Genomics Institute (IGI), Bakar Labs, project partners, researchers, and community leaders to celebrate the groundbreaking of the Innovative Genomics Institute – Bakar Labs building, marking a major milestone for one of the most transformative life sciences developments in the Bay Area. The groundbreaking represents the culmination of years of vision, planning, and collaboration among UC Berkeley, the Innovative Genomics Institute, Bakar Labs, philanthropic supporters, architects Weiss/Manfredi and DGA, engineers, consultants, and construction partners working toward a shared goal: creating a world-class hub where scientific discovery, entrepreneurship, and innovation can thrive together. The project will become a cornerstone of Berkeley’s Innovation Zone and further strengthen the city’s position as a global leader in biotechnology and climate-focused research.
Read post
Even if you've never heard of Chugai Pharmaceutical, you may have heard of some of the drugs that started there: the inflammation and autoimmune disease-fighting drug Actemra and the hemophilia drug Hemlibra, for example. Or you may recall some of its partnerships, like a pact earlier this month with age-related disease company Gero or a partnership with Eli Lilly and Co. around oral GLP-1 weight-loss drug Foundayo.
Now the Japanese drugmaker — related to Swiss drugmaker Roche and its Genentech Inc. unit — is prepping for more deals and more visibility. It is setting up a U.S. partnering beachhead in South San Francisco, a three-person office focused on connecting its antibody engineering and small-molecule expertise with life sciences innovators in academia and early-stage companies. Chugai recently became an industry affiliate of Bakar Bio Labs.
Read post
FORBES — As investment pours into longevity breakthroughs, HexemBio is taking a unique approach to the problem — tackling deterioration in the blood and immune system as the root causes of age-related deterioration.
Read post